Spatial analyses implicate high stromal tumour-infiltrating CD8+ lymphocytes as a negative predictive marker for chemotherapy in estrogen receptor-positive breast cancer. - Kinsella Z; Jahangir CA; Nyarko HN; Kalinska-Lysiak D; Gonzalez CA; Murphy V; O'Grady T; Fay J; Sheehan K; Rahman A; Crown JP; Kelly CM; et al. (Nature communications, 2026)